Head-to-head · Cost-Efficiency Index
NuuVim vs AHBARx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NuuVim
Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing.
Visit NuuVimAHBARx
Shoppers who want one number that already contains the visit fee and the shipping, and who will read the terms before subscribing.
Visit AHBARxThe verdict
NuuVim and AHBARx tie on the Cost-Efficiency Index at 70/100, so neither wins outright on the numbers. For most shoppers we'd start with NuuVim (ranked #81, a hair above #82) — Cost-first shoppers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing. But AHBARx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NuuVim.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NuuVim | AHBARx |
|---|---|---|
| Cost-Efficiency Index | 70/100 | 70/100 |
| Semaglutide / mo | $79/mo (all doses, 3-mo plan, new patients only, compounded) | $249/mo month-to-month (a $50 consultation and $25 shipping are inside the figure) |
| Tirzepatide / mo | $133/mo (all doses, 3-mo plan, new patients only, compounded) | $349/mo month-to-month (consultation and shipping included in the figure) |
| Semaglutide / yr (modeled) | $948 | $2,988 |
| Tirzepatide / yr (modeled) | $1,596 | $4,188 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #81 | #82 |
NuuVim
70/100Where the value is
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
The tradeoffs
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
AHBARx
70/100Where the value is
- Both monthly prices, the $50 consultation and the $25 shipping are itemized on a checkout panel you can reach without an account or an intake
- Names its compounding partner, AnazaoHealth, and its clinical partners, Beluga Health and Qualiphy
- Names a founding physician with credentials on the About page rather than referring only to a network
The tradeoffs
- The terms of service and the privacy policy are unedited templates: they still print "[list of Pharmacies]", "[list of Labs]", "[phone number]" and even "[www.ahbarx.com]" where the company's own details belong
- The About page says there are no membership fees while the terms require "the Weight Loss Membership on an automatically renewing monthly subscription basis" — no membership line appears at checkout, so which one governs is unclear
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.